Earnings call Dr. Lal PathLabs reported 10.7% YoY revenue growth and 19.3% PAT growth in Q3 FY25, despite no price increases. The company is executing a multi-pronged strategy of geographic expansion, ...

Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

Bengaluru: Dr. Lal Path Labs reported a ‍lower third-quarter profit on Friday after taking a one-time charge ⁠linked to India's new labour code, despite strong demand for its bundled test packages.

Discover Dr Lal Path Labs diagnostic services in New Delhi, Delhi. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information on ...

(Reuters) -Dr Lal Path Labs, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid ...

Discover Dr Lal Path Labs diagnostic services in Gurgaon, Haryana. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information on ...

Diagnostic companies Dr Lal Path Labs and Metropolis Healthcare shares were reeling under the pressure on Wednesday and declined even when the markets were trading in the green. The weakness in the ...

Stock market performance on Wednesday was fueled by the mixed reaction of investors who were cautious of US market uncertainties, declining oil prices, bond yields, and bullion. The stock market ended ...

Earnings call Dr. Lal PathLabs reported Q3 FY26 revenue of ₹660 crore, up 10.6% YoY, driven by favorable test and geography mix. EBITDA margin (pre-exceptional) improved to 27.2% despite a ₹30 crore ...